Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Lövborg

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Lakartidningen|December 14, 2016
[The new cancer drugs should be administered with individualized dosage]Curt Peterson, Henrik Lövborg
BMC Research Notes|July 1, 2009
Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drugHenrik Lövborg, Robert Burman, Joachim Gullbo
Molecular Cancer Therapeutics|May 14, 2004
Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828Henrik Lövborg, Peter Nygren, Rolf Larsson
BMC Pharmacology & Toxicology|June 11, 2014
Medication errors related to transdermal opioid patches: lessons from a regional incident reporting systemHenrik Lövborg, Mikael Holmlund, Staffan Hägg
Anti-Cancer Drugs|June 3, 2005
Screening for apoptosis--classical and emerging techniquesHenrik Lövborg, Joachim Gullbo, Rolf Larsson
Lakartidningen|December 17, 2009
[The effect of warfarin was potentiated by an antitussive. Cocillana-Etyfin increased the PK(INR) value]Henrik Lövborg, Ingela Jacobsson, Staffan Hägg
Current Drug Safety|June 6, 2012
A fatal outcome after unintentional overdosing of rivastigmine patchesHenrik Lövborg, Anna K Jönsson, Staffan Hägg
Journal of Biomolecular Screening|January 9, 2007
Image-based screening for the identification of novel proteasome inhibitorsLinda Rickardson, Malin Wickström, Rolf Larsson, et al.
Cancer Research|August 3, 2002
Action of a novel anticancer agent, CHS 828, on mouse fibroblasts: increased sensitivity of cells lacking poly (ADP-Ribose) polymerase-1Henrik Lövborg, Jacek Wojciechowski, Rolf Larsson, et al.
International Journal of Environmental Research and Public Health|July 25, 2017
Increased Risk of Drug-Induced Hyponatremia during High TemperaturesAnna K Jönsson, Henrik Lövborg, Wolfgang Lohr, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Lakartidningen|December 14, 2016
[The new cancer drugs should be administered with individualized dosage]Curt Peterson, Henrik Lövborg
BMC Research Notes|July 1, 2009
Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drugHenrik Lövborg, Robert Burman, Joachim Gullbo
Molecular Cancer Therapeutics|May 14, 2004
Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828Henrik Lövborg, Peter Nygren, Rolf Larsson
BMC Pharmacology & Toxicology|June 11, 2014
Medication errors related to transdermal opioid patches: lessons from a regional incident reporting systemHenrik Lövborg, Mikael Holmlund, Staffan Hägg
Anti-Cancer Drugs|June 3, 2005
Screening for apoptosis--classical and emerging techniquesHenrik Lövborg, Joachim Gullbo, Rolf Larsson
Lakartidningen|December 17, 2009
[The effect of warfarin was potentiated by an antitussive. Cocillana-Etyfin increased the PK(INR) value]Henrik Lövborg, Ingela Jacobsson, Staffan Hägg
Current Drug Safety|June 6, 2012
A fatal outcome after unintentional overdosing of rivastigmine patchesHenrik Lövborg, Anna K Jönsson, Staffan Hägg
Journal of Biomolecular Screening|January 9, 2007
Image-based screening for the identification of novel proteasome inhibitorsLinda Rickardson, Malin Wickström, Rolf Larsson, et al.
Cancer Research|August 3, 2002
Action of a novel anticancer agent, CHS 828, on mouse fibroblasts: increased sensitivity of cells lacking poly (ADP-Ribose) polymerase-1Henrik Lövborg, Jacek Wojciechowski, Rolf Larsson, et al.
International Journal of Environmental Research and Public Health|July 25, 2017
Increased Risk of Drug-Induced Hyponatremia during High TemperaturesAnna K Jönsson, Henrik Lövborg, Wolfgang Lohr, et al.
Pageof 3